Diopsys, Inc. Agrees To Pay Up To $14.25 Million To Resolve Alleged Federal False Claims Act And State Law Violations Relating To Vision Testing
Newark, N.J. – Diopsys, Inc., a medical device company based in Middletown, Pennsylvania, has agreed to pay up to $14.25 million to resolve allegations that the company violated the federal False Claims Act and various state laws by knowingly submitting or causing others to submit false claims for payment to Medicare and Medicaid in connection with certain vision testing services, U.S. Attorney John Giordano announced today.
Action Details
- Date:March 27, 2025
- Agency:U.S. Attorney's Office, District of New Jersey
-
Enforcement Types:
- Criminal and Civil Actions
.png){kind=logo}